Cargando…
Dissecting the role of EYS in retinal degeneration: clinical and molecular aspects and its implications for future therapy
Mutations in the EYS gene are one of the major causes of autosomal recessive retinitis pigmentosa. EYS-retinopathy presents a severe clinical phenotype, and patients currently have no therapeutic options. The progress in personalised medicine and gene and cell therapies hold promise for treating thi...
Autores principales: | Garcia-Delgado, Ana B., Valdes-Sanchez, Lourdes, Morillo-Sanchez, Maria Jose, Ponte-Zuñiga, Beatriz, Diaz-Corrales, Francisco J., de la Cerda, Berta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127272/ https://www.ncbi.nlm.nih.gov/pubmed/34001227 http://dx.doi.org/10.1186/s13023-021-01843-z |
Ejemplares similares
-
EYS mutations and implementation of minigene assay for variant classification in EYS-associated retinitis pigmentosa in northern Sweden
por: Westin, Ida Maria, et al.
Publicado: (2021) -
Retinal pigment epithelium degeneration caused by aggregation of PRPF31 and the role of HSP70 family of proteins
por: Valdés-Sánchez, Lourdes, et al.
Publicado: (2019) -
Eyes shut homolog (EYS) interacts with matriglycan of O-mannosyl glycans whose deficiency results in EYS mislocalization and degeneration of photoreceptors
por: Liu, Yu, et al.
Publicado: (2020) -
Mesoporous Silica-Based Nanoparticles as Non-Viral Gene Delivery Platform for Treating Retinitis Pigmentosa
por: Valdés-Sánchez, Lourdes, et al.
Publicado: (2022) -
Genotypes Influence Clinical Progression in EYS-Associated Retinitis Pigmentosa
por: Lo, Jui-En, et al.
Publicado: (2022)